Dementia News and Research

Latest Dementia News and Research

The Shriver Report reveals AD’s epidemic effect on women

Maria Shriver and the Alzheimer's Association the leader in Alzheimer's care, support and research today released The Shriver Report: A Woman's Nation Takes on Alzheimer's. This groundbreaking report reveals the epidemic's effect on women as caregivers, advocates and people living with this disease.

14 Oct 2010

EFNS recommends use of DaTSCAN injection with SPECT imaging for AD diagnosis

GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.

14 Oct 2010

GSA and NAM select journalists for new MetLife Foundation Journalists in Aging Fellows Program

The Gerontological Society of America (GSA) and New America Media (NAM) have selected 15 journalists for the new MetLife Foundation Journalists in Aging Fellows Program. They represent a wide range of traditional, new, and ethnic media, such as USA Today, Sing Tao Daily, the Minneapolis Star Tribune, and TheAtlantic.com.

14 Oct 2010

Walking six miles per week preserves memory in old age

New research suggests that walking at least six miles per week may protect brain size and in turn, preserve memory in old age, according to a study published in the October 13, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Oct 2010

MetLife study finds Adult Day Services centers are increasing in the U.S.

There has been significant growth in the number of Adult Day Services centers in the U.S. over the past eight years, according to a new study by the MetLife Mature Market Institute. As reported in "The MetLife National Study of Adult Day Services: Providing Support to Individuals and Their Family Caregivers," there are more than 4,600 Adult Day Services (ADS) centers nationwide, a 35% increase since 2002.

13 Oct 2010

Nutrition for the aged

Experts believe nutrition in the aged needs to be a priority. They say that it should be ensured that the aged get access to good, nutritious food during the winter months.

12 Oct 2010

Adeona announces five scientific publications on Alzheimer's disease and cognitive decline

Adeona Pharmaceuticals, Inc., announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer's disease and cognitive decline.

12 Oct 2010

Lundbeck, Merck announce commercialization agreement for SYCREST sublingual tablets

H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.

12 Oct 2010

Women with epilepsy at risk of infertility

Women with epilepsy may be more likely to experience infertility, according to new research published in the October 12, 2010, print issue of Neurology, the medical journal of the American Academy of Neurology.

12 Oct 2010

COU-AA-301 Phase 3 study demonstrates improvement in CRPC survival rate

Results from a pre-specified interim analysis of a randomized, placebo-controlled Phase 3 study, COU-AA-301, demonstrate that patients treated with the investigational agent abiraterone acetate plus low-dose prednisone/prednisolone showed a significant improvement in overall survival compared to patients treated with prednisone/prednisolone plus placebo.

11 Oct 2010

AFA quarterly magazine features President Obama as guest columnist

President Obama is featured as a guest columnist in the latest issue of the Alzheimer's Foundation of America's (AFA) quarterly magazine for caregivers of individuals with Alzheimer's disease and related illnesses, care ADvantage. In his column, he outlines important provisions in the Affordable Care Act that are relevant to the Alzheimer's community, such as health insurance, drug coverage and long-term care.

8 Oct 2010

Latino community not aware of Alzheimer's disease: Survey

According to the Alzheimer's Association "Hispanic Perceptions of Alzheimer's Disease" survey, which was funded by MetLife Foundation and released today during National Hispanic Heritage Month, 64 percent of survey respondents felt that the Latino community is not very aware or not at all aware of Alzheimer's disease.

6 Oct 2010

Low level of testosterone increases risk for Alzheimer's disease

Low levels of the male sex hormone, testosterone, in older men is associated with the onset of Alzheimer's disease, according to research by a team that includes a Saint Louis University scientist.

6 Oct 2010

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.

6 Oct 2010

Caring.com introduces interactive Alzheimer’s resource for caregivers

Caring.com today launched Steps & Stages, the first-ever interactive guide, support system, and customized e-mail newsletter that delivers specific, stage-appropriate advice for those providing care for a loved one with Alzheimer's or another form of dementia.

5 Oct 2010

Intellect Neurosciences receives patent for Alzheimer's disease monoclonal antibody program

Intellect Neurosciences, Inc., a biopharmaceutical company with internal preclinical and clinical-stage pipelines, as well as multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a patent from the United States Patent and Trademark Office (USPTO) related to its internal Alzheimer's disease (AD) monoclonal antibody program.

5 Oct 2010

Researchers investigate ways to increase survival rate in patients with Parkinson's disease

New research shows how old people are when they first develop Parkinson's disease is one of many clues in how long they'll survive with the disease. The research is published in the October 5, 2010, print issue of Neurology, the medical journal of the American Academy of Neurology.

5 Oct 2010

Neuro-Biotech introduces biomarker for progressive clinical investigation on Alzheimer's Disease

Neuro-Biotech Corporation introduces a Neuro-biomarker which is linked to a series of Neuro-Bio tests. This will permit to understand the science behind them and how they each will contribute to a progressive clinical investigation involving the input and output of the brain.

5 Oct 2010

Second pathway to brain’s memory function uncovered

Australian and US scientists have successfully identified a new mechanism by which the brain learns and stores memories. This could spell hope for brain injuries and diseases like Alzheimer’s disease.

4 Oct 2010

Welch Allyn launches Connex ProBP handheld automated digital blood pressure device

Welch Allyn, a leading global provider of frontline medical products and solutions, today introduced the Connex® ProBP™ 3400, an automated digital blood pressure device designed to fit in the palm of the hand. Borrowing Welch Allyn SureBP™ technology from the company's multiparameter vital signs devices, the Connex ProBP delivers fast, accurate blood pressure readings with the durability of Welch Allyn's popular hospital-grade vital signs devices.

4 Oct 2010

Dementia News and Research

Latest Dementia News and Research

The Shriver Report reveals AD’s epidemic effect on women

EFNS recommends use of DaTSCAN injection with SPECT imaging for AD diagnosis

GSA and NAM select journalists for new MetLife Foundation Journalists in Aging Fellows Program

Walking six miles per week preserves memory in old age

MetLife study finds Adult Day Services centers are increasing in the U.S.

Nutrition for the aged

Adeona announces five scientific publications on Alzheimer's disease and cognitive decline

Lundbeck, Merck announce commercialization agreement for SYCREST sublingual tablets

Women with epilepsy at risk of infertility

COU-AA-301 Phase 3 study demonstrates improvement in CRPC survival rate

AFA quarterly magazine features President Obama as guest columnist

Latino community not aware of Alzheimer's disease: Survey

Low level of testosterone increases risk for Alzheimer's disease

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

Caring.com introduces interactive Alzheimer’s resource for caregivers

Intellect Neurosciences receives patent for Alzheimer's disease monoclonal antibody program

Researchers investigate ways to increase survival rate in patients with Parkinson's disease

Neuro-Biotech introduces biomarker for progressive clinical investigation on Alzheimer's Disease

Second pathway to brain’s memory function uncovered

Welch Allyn launches Connex ProBP handheld automated digital blood pressure device

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Dementia News and Research

Latest Dementia News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in